Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Jing Pan, MD, Tong Wu, MD, Jun-Fang Yang, MD, Jian-Ping Zhang, Yan-Li Zhao, Yang Zhang, MD, Hong-Xing Liu, MD, Chun-Rong Tong, MD

Blood (2016) 128 (22): 3985.

https://doi.org/10.1182/blood.V128.22.3985.3985

Published: 2016

Journal Articles

Arsenic Containing Triple-Agent Therapy for Acute Promyelocytic Leukemia-Comparison of Tetra-Arsenic Tetra-Sulfide vs. Arsenic Trioxide in the Long-Term Follow-up at a Single Hospital.

Shu-Lan Wu, MD, Dao-Pei Lu, MD, Yan-Li Zhao, MD, Lan-Qing Liang, MD, Jun-Bao He, MD, Wei Zou, MD, Xin-Hong Fei, MD, Bin Jiang, MD, Fu-Xiang Shan, MD, Ping-Di Yang, MD, Jie Zhao, MD, Chun-Rong Tong, MD

Blood (2010) 116 (21): 1081.

https://doi.org/10.1182/blood.V116.21.1081.1081

Published: 2010

Journal Articles

Adoptive Immune Cell Therapy for the Control of Fungal Infections in Hematopoietic Stem Cell Transplant Patients

Lung-Ji Chang, PhD, Yin Liang, Lily Lien, Chun- Rong Tong, MD, Lu-Jia Dong, MD, Tong Wu, MD, Yinchieh Fu, Fu-Hung Yang, Jih-Luh Tang, MD, PhD, Dao-Pei Lu, MD

Blood (2008) 112 (11): 4358.

https://doi.org/10.1182/blood.V112.11.4358.4358

Published: 2008

Journal Articles

Escape of Minor Histocompatibility Antigen-Restricted Anti-Leukemia Immunity Associated with Loss of Specific HLA-I Locus Expression in a Leukemia Patient after an Intensive Immunotherapy.

Lung-Ji Chang, PhD, Chun-Rong Tong, MD, Jih-Luh Tang, MD PhD, Yoshiki Akatsuka, MD PhD, Shuhong Han, PhD, Yin Liang, MSc, Chi-Cheng Li, MD, Lujia Dong, MD, Tong Wu, MD, Dao-Pei Lu, MD

Blood (2007) 110 (11): 4895.

https://doi.org/10.1182/blood.V110.11.4895.4895

Published: 2007

Journal Articles

Targeting Late Relapsed Acute Myeloid Leukemia Cells by Cytotoxic T Cells Generated from Late but Not Early Leukemic Antigen-Presenting Dendritic Cells.

Yin Liang, MSc, Lily Lien, MSc, Shuhong Han, PhD, Chun-Rong Tong, MD, Zhi-Yong Gao, MD, Tong Wu, MD, Jih-Luh Tang, MD PhD, Dao-Pei Lu, MD, Lung-Ji Chang, PhD

Blood (2007) 110 (11): 4902.

https://doi.org/10.1182/blood.V110.11.4902.4902

Published: 2007

NARROW

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Arsenic Containing Triple-Agent Therapy for Acute Promyelocytic Leukemia-Comparison of Tetra-Arsenic Tetra-Sulfide vs. Arsenic Trioxide in the Long-Term Follow-up at a Single Hospital.

Adoptive Immune Cell Therapy for the Control of Fungal Infections in Hematopoietic Stem Cell Transplant Patients

Escape of Minor Histocompatibility Antigen-Restricted Anti-Leukemia Immunity Associated with Loss of Specific HLA-I Locus Expression in a Leukemia Patient after an Intensive Immunotherapy.

Targeting Late Relapsed Acute Myeloid Leukemia Cells by Cytotoxic T Cells Generated from Late but Not Early Leukemic Antigen-Presenting Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

Clinical Features and Outcome of 22 Leukemia Patients with TLS-ERG Fusion Gene

Arsenic Containing Triple-Agent Therapy for Acute Promyelocytic Leukemia-Comparison of Tetra-Arsenic Tetra-Sulfide vs. Arsenic Trioxide in the Long-Term Follow-up at a Single Hospital.

Adoptive Immune Cell Therapy for the Control of Fungal Infections in Hematopoietic Stem Cell Transplant Patients

Escape of Minor Histocompatibility Antigen-Restricted Anti-Leukemia Immunity Associated with Loss of Specific HLA-I Locus Expression in a Leukemia Patient after an Intensive Immunotherapy.

Targeting Late Relapsed Acute Myeloid Leukemia Cells by Cytotoxic T Cells Generated from Late but Not Early Leukemic Antigen-Presenting Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only